[1]
V. Gonzalez-Uribe, “Real-world effectiveness and safety of dupilumab in children with atopic dermatitis: a Latin American single-center study”, Allergol Immunopathol, vol. 54, no. 2, pp. 28–34, Mar. 2026, doi: 10.15586/aei.v54i2.1402.